Journal of Respiratory Medicine
Open Access

Penicillin’s in the Treatment of Respiratory Infections

Received Date: Oct 30, 2023 / Published Date: Nov 29, 2023

Citation: Vilozni D (2023) Penicillin’s in the Treatment of Respiratory Infections. J Respir Med 5: 189DOI: 10.4172/jrm.1000189

Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156

Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2023 Vilozni D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF

In addition to bronchodilators, several other drug groups are frequently used in the treatment of respiratory disorders, decongestants, antihistamines, antitussives, muco-kinetics, respiratory stimulants and depressants, and paralyzing and antimicrobial agents. The drug grouping may provide clues regarding the nature of the problem for which it was taken, or vice versa. For example, a patient experiencing mucosal oedema may complain of feeling stuffed up and the patient may be taking an over-the-counter decongestant or antihistamine. The common cold, allergies, and many respiratory infections have in common the symptoms of runny nose and stuffy head. Decongestants are used to treat this upper
airway mucosal oedema and discharge.

Keywords